SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Liu YZ, Liu YJ, Recker RR, Deng HW 2003 Molecular studies of identification of genes for osteoporosis: The 2002 update. J Endocrinol 177: 147196.
  • 2
    Blank RD 2001 Breaking down bone strength: A perspective on the future of skeletal genetics. J Bone Miner Res 16: 12071211.
  • 3
    Nguyen TV, Eisman JA 2000 Genetics of fracture: Challenges and opportunities. J Bone Miner Res 15: 12531256.
  • 4
    Nguyen TV, Blangero J, Eisman JA 2000 Genetic epidemiological approaches to the search for osteoporosis genes. J Bone Miner Res 15: 392401.
  • 5
    Audi L, Garcia-Ramirez M, Carrascosa A 1999 Genetic determinants of bone mass. Horm Res 51: 105123.
  • 6
    Baldock PA, Eisman JA 2004 Genetic determinants of bone mass. Curr Opin Rheumatol 16: 450456.
  • 7
    Eisman JA 1999 Genetics of osteoporosis. Endocr Rev 20: 788804.
  • 8
    Huang QY, Recker RR, Deng HW 2003 Searching for osteoporosis genes in the post-genome era: Progress and challenges. Osteoporos Int 14: 701715.
  • 9
    Peacock M, Turner CH, Econs MJ, Foroud T 2002 Genetics of osteoporosis. Endocr Rev 23: 303326.
  • 10
    Ralston SH 2003 Genetic determinants of susceptibility to osteoporosis. Curr Opin Pharmacol 3: 286290.
  • 11
    Rizzoli R, Bonjour JP, Ferrari SL 2001 Osteoporosis, genetics and hormones. J Mol Endocrinol 26: 7994.
  • 12
    Stewart TL, Ralston SH 2000 Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 166: 235245.
  • 13
    Zmuda JM, Cauley JA, Ferrell RE 1999 Recent progress in understanding the genetic susceptibility to osteoporosis. Genet Epidemiol 16: 356367.
  • 14
    Shen H, Recker RR, Deng HW 2003 Molecular and genetic mechanisms of osteoporosis: Implication for treatment. Curr Mol Med 3: 737757.
  • 15
    Dvornyk V, Shen H, Liu YJ, Xiao P, Recker R, Deng HW 2004 Systematic approaches to the study of complex bone disorders at whole-genome level. Curr Genomics 5: 93108.
  • 16
    Shen H, Liu YJ, Liu PY, Recker RR, Deng HW 2005 Non-replication in genetic studies of complex diseases—lessons learned from studies of osteoporosis and tentative remedies. J Bone Miner Res 20: 365376.
  • 17
    Gorai I, Inada M, Morinaga H, Uchiyama Y, Yamauchi H, Chaki O, Hirano H 2004 Cytochrome P450c17α(CYP17) gene polymorphism indirectly influences on bone density through their effects on endogenous androgen in postmenopausal Japanese women-Are the effects of age and body mass index greater than those of endogenous sex steroids? J Bone Miner Res 19: S382.
  • 18
    Napoli N, Mumm S, Sheik S, Rini GB, Villareal RC 2004 Effect of CYP450 gene polymorphisms on estrogen metabolism and bone density. J Bone Miner Res 19: S384.
  • 19
    Ezura Y, Nakajima T, Kajita M, Ishida R, Inoue S, Yoshida H, Suzuki T, Shiraki M, Hosoi T, Orimo H, Emi M 2003 Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res 18: 16421649.
  • 20
    Dennison EM, Syddall HE, Rodriguez S, Voropanov A, Day IN, Cooper C 2004 Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass. J Clin Endocrinol Metab 89: 48984903.
  • 21
    Iwasaki H, Emi M, Ezura Y, Ishida R, Kajita M, Kodaira M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Swensen J, Orimo H 2003 Association of a Trp16Ser variation in the gonadotropin releasing hormone signal peptide with bone mineral density, revealed by SNP-dependent PCR typing. Bone 32: 185190.
  • 22
    Langdahl BL, Husted LB, Stenkjaer L, Carstens M 2004 Polymorphisms in the IGF-II gene are associated with body weight and bone mass. J Bone Miner Res 19: S385.
  • 23
    Koh JM, Kim DJ, Hong JS, Park JY, Lee KU, Kim SY, Kim GS 2002 Estrogen receptor alpha gene polymorphisms Pvu II and Xba I influence association between leptin receptor gene polymorphism (Gln223Arg) and bone mineral density in young men. Eur J Endocrinol 147: 777783.
  • 24
    Boot AM, Wilson SG, Dick IM, Islam AFM, Ueland T, Devine A, Prince RL 2004 LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. J Bone Miner Res 19: S383.
  • 25
    Yamada Y, Ando F, Niino N, Shimokata H 2003 Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J Clin Endocrinol Metab 88: 33723378.
  • 26
    Yamada Y, Ando F, Niino N, Shimokata H 2002 Association of a polymorphism of the CC chemokine receptor-2 gene with bone mineral density. Genomics 80: 812.
  • 27
    Kornak U, Branger S, Ostertag A, de Vernejoul MC 2004 A VNTR in the CLCN7 gene influences bone density in patients with autosomal dominant osteopetrosis (ADO) type II and in post-menopausal women. J Bone Miner Res 19: S387.
  • 28
    Eriksson A, Lorentzon M, Anderson N, Mellstrom D, Ohlsson C 2004 The catechol-O-methyltransferase val158met polymorphism is associated with bone mineral density in young adult men. J Bone Miner Res 19: S131.
  • 29
    Giraudeau FS, McGinnis RE, Gray IC, O'Brien EJ, Doncaster KE, Spurr NK, Ralston SH, Reid DM, Wood J 2004 Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from Scotland. J Bone Miner Res 19: 3141.
    Direct Link:
  • 30
    Yamada Y, Ando F, Niino N, Shimokata H 2003 Association of a polymorphism of the dopamine receptor D4 gene with bone mineral density in Japanese men. J Hum Genet 48: 629633.
  • 31
    Ishida R, Ezura Y, Emi M, Kajita M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Ito H, Orimo H 2003 Association of a promoter haplotype (-1542G/-525C) in the tumor necrosis factor receptor associated factor-interacting protein gene with low bone mineral density in Japanese women. Bone 33: 237241.
  • 32
    Enattah N, Valimaki VV, Valimaki MJ, Loyttyniemi E, Sahi T, Jarvela I 2004 Molecularly defined lactose malabsorption, peak bone mass and bone turnover rate in young Finnish men. Calcif Tissue Int 75: 488493.
  • 33
    Joseph C, Prestwood KM, Burleson JA, Gregersen PK, Lee A, Bucala R, Kuchel GA, Kenny AM 2004 Macrophage migration inhibitory factor (MIF) gene promoter region polymorphism and femoral neck bone density. J Bone Miner Res 19: S130S131.
  • 34
    Yamada Y, Ando F, Niino N, Shimokata H 2002 Association of a polymorphism of the matrix metalloproteinase-1 gene with bone mineral density. Matrix Biol 21: 389392.
  • 35
    Yamada Y, Ando F, Niino N, Shimokata H 2004 Association of a polymorphism of the matrix metalloproteinase-9 gene with bone mineral density in Japanese men. Metabolism 53: 135137.
  • 36
    Zmuda JM, Cauley JA, Ferrel RE 2004 Nuclear receptor coativator-3 (NCO A3/AIB1/SRC3) alleles are a strong correlate of bioavailable testosterone and vertebral bone mass in older men. J Bone Miner Res 19: S387.
  • 37
    Heikkinen AM, Niskanen LK, Salmi JA, Koulu M, Pesonen U, Uusitupa MI, Komulainen MH, Tuppurainen MT, Kroger H, Jurvelin J, Saarikoski S 2004 Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women. Bone 35: 589594.
  • 38
    Koh J, Park E, Kim G, Shin H, Kim S 2004 Polymorphisms in the osteoclast-associated receptor gene are associated with risk of osteopenia and osteoporosis. J Bone Miner Res 19: S384.
  • 39
    Spotila LD, Rodriguez H, Koch M, Tenenhouse HS, Tenenhouse A, Li H, Devoto M 2003 Association analysis of bone mineral density and single nucleotide polymorphisms in two candidate genes on chromosome 1p36. Calcif Tissue Int 73: 140146.
  • 40
    Yamada Y, Ando F, Niino N, Miki T, Shimokata H 2003 Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese. J Hum Genet 48: 469475.
  • 41
    Omasu F, Ezura Y, Kajita M, Ishida R, Kodaira M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Orimo H, Emi M 2003 Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women. J Hum Genet 48: 342345.
  • 42
    Haney EM, Marshall L, Lambert L, Zmuda J, Stone K, Orwoll E, Bliziotes M 2004 An intron 2 polymorphism at the serotonin transporter is associated with reduced hip bone mineral density. J Bone Miner Res 19: S131.
  • 43
    Balemans W, Foernzler D, Parsons C, Ebeling M, Thompson A, Reid DM, Lindpaintner K, Ralston SH, Van Hul W 2002 Lack of association between the SOST gene and bone mineral density in perimenopausal women: Analysis of five polymorphisms. Bone 31: 515519.
  • 44
    Sobacchi C, Vezzoni P, Reid DM, McGuigan FE, Frattini A, Mirolo M, Albhaga OM, Musio A, Villa A, Ralston SH 2004 Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in women. Calcif Tissue Int 74: 3541.
  • 45
    Munafo MR, Flint J 2004 Meta-analysis of genetic association studies. Trends Genet 20: 439444.
  • 46
    Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, Kubota M, Yoshida S, Ikeda M, Watabe F, Kanemasa Y, Takeda E 2001 The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res 16: 12561264.
  • 47
    Morita A, Iki M, Dohi Y, Ikeda Y, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F 2004 Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study. Int J Epidemiol 33: 979988.
  • 48
    Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG 2003 Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res 18: 16321641.
  • 49
    Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J 2004 Meta-analysis of molecular association studies: Vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res 19: 419428.
  • 50
    Thakkinstian A, D'Este C, Attia J 2004 Haplotype analysis of VDR gene polymorphisms: A meta-analysis. Osteoporos Int 15: 729734.
  • 51
    Morrison N 2004 Commentary: Vitamin D receptor polymorphism and bone mineral density: Effect size in Caucasians means detection is uncertain in small studies. Int J Epidemiol 33: 989994.
  • 52
    Fang Y, van Meurs J, Zhao HY, van Leeuwen J, Pols H, Utterlinden A 2004 Intragenic interaction of VDR haplotype alleles determines fracture risk. J Bone Miner Res 19: S385.
  • 53
    Nejentsev S, Godfrey L, Snook H, Rance H, Nutland S, Walker NM, Lam AC, Guja C, Ionescu-Tirgoviste C, Undlien DE, Ronningen KS, Tuomilehto-Wolf E, Tuomilehto J, Newport MJ, Clayton DG, Todd JA 2004 Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet 13: 16331639.
  • 54
    van Meurs J, Zillikens C, Fang Y, Zhao H, van Leeuwen J, Hofman A, Obermayer-Pietsch B, Pols H, Utterlinden A 2004 A DNA variant correlated to lactose intolerance Interacts with VDR gene variants to determine height, bone geometry and BMD. J Bone Miner Res 19: S385.
  • 55
    Clark AG 2004 The role of haplotypes in candidate gene studies. Genet Epidemiol 27: 321333.
  • 56
    Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES 2000 The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26: 7680.
  • 57
    Yamada Y, Ando F, Niino N, Ohta S, Shimokata H 2002 Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density of the femoral neck in elderly Japanese women. J Mol Med 80: 452460.
  • 58
    Zhao LJ, Liu PY, Long JR, Lu Y, Xu FH, Zhang YY, Shen H, Xiao P, Elze L, Recker RR, Deng HW 2004 Test of linkage and/or association between the estrogen receptor alpha gene with bone mineral density in Caucasian nuclear families. Bone 35: 395402.
  • 59
    Qin YJ, Shen H, Huang QR, Zhao LJ, Zhou Q, Li MX, He JW, Mo XY, Lu JH, Recker RR, Deng HW 2003 Estrogen receptor alpha gene polymorphisms and peak bone density in Chinese nuclear families. J Bone Miner Res 18: 10281035.
  • 60
    van Meurs JB, Schuit SC, Weel AE, van der Klift M, Bergink AP, Arp PP, Colin EM, Fang Y, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG 2003 Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet 12: 17451754.
  • 61
    Ioannidis J, Ralston S, Bennett S, Brandi M, Grinberg D, Karassa F, Langdahl B, van Meurs J, Mosekilde L, Scollen S, Albagha O, Bustamante M, Carey A, Dunning A, Enjuanes A, van Leeuwen J, Mavilia C, Masi L, McGuigan F, Nogues X, Pols H, Reid D, Schuit S, Sherlock R, Utterlinden A 2004 Large-scale evidence for differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes: The GENOMOS study. J Bone Miner Res 292: 21052114.
  • 62
    Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN 2003 Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177182.
  • 63
    Gerdhem P, Brandstrom H, Stiger F, Obrant K, Melhus H, Ljunggren O, Kindmark A, Akesson K 2004 Association of the collagen type 1 (COL1A 1) Sp1 binding site polymorphism to femoral neck bone mineral density and wrist fracture in 1044 elderly Swedish women. Calcif Tissue Int 74: 264269.
  • 64
    Zhang YY, Lei SF, Mo XY, Wang YB, Li MX, Deng HW 2005 The 1997 G/T polymorphism in the COLIA1 upstream regulatory region is associated with hip bone mineral density (BMD) in Chinese nuclear families. Calcif Tissue Int 76: 107112.
  • 65
    Long JR, Liu PY, Lu Y, Xiong DH, Zhao LJ, Zhang YY, Elze L, Recker RR, Deng HW 2004 Association between COL1A1 gene polymorphisms and bone size in Caucasians. Eur J Hum Genet 12: 383388.
  • 66
    Mann V, Ralston SH 2003 Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 32: 711717.
  • 67
    Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM, Ralston SH 2001 A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107: 899907.
  • 68
    The International HapMap Project 2003 Nature 426: 789796.
  • 69
    Passaro A, Vanini A, Calzoni F, Alberti L, Zamboni PF, Fellin R, Solini A 2001 Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157: 175180.
  • 70
    Hak AE, Polderman KH, Westendorp IC, Jakobs C, Hofman A, Witteman JC, Stehouwer CD 2000 Increased plasma homocysteine after menopause. Atherosclerosis 149: 163168.
  • 71
    Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R 1994 Human methylenetetrahydrofolate reductase: Isolation of cDNA mapping and mutation identification. Nat Genet 7: 551.
  • 72
    Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP 1995 A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111113.
  • 73
    Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, Shiraki M, Yazaki Y, Ouchi Y 2000 Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66: 190194.
  • 74
    Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L 2003 A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: Longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 18: 723729.
  • 75
    Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R 1996 Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93: 79.
  • 76
    McLean RR, Karasik D, Selhub J, Tucker KL, Ordovas JM, Russo GT, Cupples LA, Jacques PF, Kiel DP 2004 Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 19: 410418.
  • 77
    Macdonald HM, McGuigan FE, Fraser WD, New SA, Ralston SH, Reid DM 2004 Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 35: 957964.
  • 78
    Macdonald HM, McGuigan FE, Ralston SH, Reid DM 2004 Association of apolipoprotein E genotypes with bone mineral density and bone loss in early postmenopausal Scottish women: No evidence of gene nutrient interaction with dietary vitamin K or fat. J Bone Miner Res 19: S422S423.
  • 79
    Long JR, Liu PY, Liu YJ, Lu Y, Shen H, Zhao LJ, Xiong DH, Deng HW 2004 APOE haplotypes influence bone mineral density in Caucasian males but not females. Calcif Tissue Int 75: 299304.
  • 80
    Janssen JA, Burger H, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW, Pols HA 1998 Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol 138: 627632.
  • 81
    Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP 1997 Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82: 27992805.
  • 82
    Rivadeneira F, Houwing-Duistermaat JJ, Vaessen N, Vergeer-Drop JM, Hofman A, Pols HA, van Duijn CM, Uitterlinden AG 2003 Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: The Rotterdam Study. J Clin Endocrinol Metab 88: 38783884.
  • 83
    Rivadeneira F, Houwing-Duistermaat JJ, Beck TJ, Janssen JA, Hofman A, Pols HA, van Duijn CM, Uitterlinden AG 2004 The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: The Rotterdam Study. J Bone Miner Res 19: 12801290.
  • 84
    Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T 1990 IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145: 32973303.
  • 85
    Moffett SP, Zmuda JM, Cauley JA, Stone KL, Nevitt MC, Ensrud KE, Hillier TA, Hochberg MC, Joslyn G, Morin P, Cummings SR 2004 Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res 19: 16121618.
  • 86
    Bollerslev J, Wilson SG, Dick IM, Devine A, Dhaliwal SS, Prince RL 2004 Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderly women. Calcif Tissue Int 74: 1217.
  • 87
    Dick IM, Devine A, Li S, Dhaliwal SS, Prince RL 2003 The T869C TGF beta polymorphism is associated with fracture, bone mineral density, and calcaneal quantitative ultrasound in elderly women. Bone 33: 335341.
  • 88
    Shearman AM, Karasik D, Gruenthal KM, Demissie S, Cupples LA, Housman DE, Kiel DP 2004 Estrogen receptor beta polymorphisms are associated with bone mass in women and men: The Framingham Study. J Bone Miner Res 19: 773781.
    Direct Link:
  • 89
    Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15: 212.
  • 90
    Yamada Y, Ando F, Niino N, Shimokata H 2003 Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. Mol Genet Metab 80: 344349.
  • 91
    Tofteng CL, Kindmark A, Brandstrom H, Abrahamsen B, Petersen S, Stiger F, Stilgren LS, Jensen JE, Vestergaard P, Langdahl BL, Mosekilde L 2004 Polymorphisms in the CYP19 and AR genes–relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study. Calcif Tissue Int 74: 2534.
  • 92
    Albagha OM, Tasker PN, McGuigan FE, Reid DM, Ralston SH 2002 Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. Hum Mol Genet 11: 22892295.
  • 93
    Moffett SP, Zmuda JM, Oakley JI, Beck TJ, Cauley JA, Stone KL, Lui L, Ensrud KE, Hillier TA, Hochberg MC, Morin P, Green D, Peltz G 2004 Tumor necrosis factor alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Bone Miner Res 19: S250.
  • 94
    Johnson ML, Harnish K, Nusse R, Van Hul W 2004 LRP5 and Wnt signaling: A union made for bone. J Bone Miner Res 19: 17491757.
  • 95
    Johnson ML, Gong G, Kimberling W, Recker SM, Kimmel DB, Recker RB 1997 Linkage of a gene causing high bone mass to human chromosome 11 (11q12–13). Am J Hum Genet 60: 13261332.
  • 96
    Koh JM, Jung MH, Hong JS, Park HJ, Chang JS, Shin HD, Kim SY, Kim GS 2004 Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J Korean Med Sci 19: 407412.
  • 97
    Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R, Antonarakis SE 2004 Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet 74: 866875.
  • 98
    Pritchard JK, Stephens M, Donnelly P 2000 Inference of population structure using multilocus genotype data. Genetics 155: 945959.
  • 99
    Koller DL, Rodriguez LA, Christian JC, Slemenda CW, Econs MJ, Hui SL, Morin P, Conneally PM, Joslyn G, Curran ME, Peacock M, Johnston CC, Foroud T 1998 Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12–13. J Bone Miner Res 13: 19031908.
  • 100
    Bollerslev J, Wilson SG, Dick IM, Islam AFM, Ueland T, Devine A, Prince RL 2004 LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. J Bone Miner Res 19: S383.
  • 101
    Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J 2001 Bone dysplasia sclerostenosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68: 577589.
  • 102
    Uitterlinden AG, Arp PP, Paeper BW, Charmley P, Proll S, Rivadeneira F, Fang Y, van Meurs JB, Britschgi TB, Latham JA, Schatzman RC, Pols HA, Brunkow ME 2004 Polymorphisms in the sclerostenosis/van Buchem disease gene (SOST) region are associated with bone mineral density in elderly whites. Am J Hum Genet 75: 10321045.
  • 103
    Freimer N, Sabatti C 2004 The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet 36: 10451051.
  • 104
    Huizinga TW, Pisetsky DS, Kimberly RP 2004 Associations, populations, and the truth: Recommendations for genetic association studies in arthritis and rheumatism. Arthritis Rheum 50: 20662071.
  • 105
    Cardon LR, Bell JI 2001 Association study designs for complex diseases. Nat Rev Genet 2: 9199.
  • 106
    Romero R, Kuivaniemi H, Tromp G, Olson J 2002 The design, execution, and interpretation of genetic association studies to decipher complex diseases. Am J Obstet Gynecol 187: 12991312.
  • 107
    Zondervan KT, Cardon LR 2004 The complex interplay among factors that influence allelic association. Nat Rev Genet 5: 89100.
  • 108
    Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG 2003 Genetic associations in large versus small studies: An empirical assessment. Lancet 361: 567571.
  • 109
    Weiss KM, Clark AG 2002 Linkage disequilibrium and the mapping of complex human traits. Trends Genet 18: 1924.
  • 110
    Ardlie KG, Kruglyak L, Seielstad M 2002 Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 3: 299309.
  • 111
    Cardon LR, Abecasis GR 2003 Using haplotype blocks to map human complex trait loci. Trends Genet 19: 135140.
  • 112
    Shifman S, Kuypers J, Kokoris M, Yakir B, Darvasi A 2003 Linkage disequilibrium patterns of the human genome across populations. Hum Mol Genet 12: 771776.
  • 113
    Neale BM, Sham PC 2004 The future of association studies: Gene-based analysis and replication. Am J Hum Genet 75: 353362.
  • 114
    Benjamini Y, Hochberg Y 1995 Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289300.
  • 115
    Doerge RW, Churchill GA 1996 Permutation tests for multiple loci affecting a quantitative character. Genetics 142: 285294.
  • 116
    McIntyre LM, Martin ER, Simonsen KL, Kaplan NL 2000 Circumventing multiple testing: A multilocus Monte Carlo approach to testing for association. Genet Epidemiol 19: 1829.
  • 117
    Deng HW 2001 Population admixture may appear to mask, change or reverse genetic effects of genes underlying complex traits. Genetics 159: 13191323.
  • 118
    Thomas DC, Witte JS 2002 Point: Population stratification: A problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 11: 505512.
  • 119
    Wacholder S, Rothman N, Caporaso N 2002 Counterpoint: Bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 11: 513520.
  • 120
    Cardon LR, Palmer LJ 2003 Population stratification and spurious allelic association. Lancet 361: 598604.
  • 121
    Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D 2004 Assessing the impact of population stratification on genetic association studies. Nat Genet 36: 388393.
  • 122
    Marchini J, Cardon LR, Phillips MS, Donnelly P 2004 The effects of human population structure on large genetic association studies. Nat Genet 36: 512517.
  • 123
    Helgason A, Yngvadottir B, Hrafnkelsson B, Gulcher J, Stefansson K 2004 An Icelandic example of the impact of population structure on association studies. Nat Genet 37: 9095.
  • 124
    Spielman RS, Ewens WJ 1996 The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 59: 983989.
  • 125
    Spielman RS, McGinnis RE, Ewens WJ 1993 Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506516.
  • 126
    Devlin B, Roeder K 1999 Genomic control for association studies. Biometrics 55: 9971004.
  • 127
    Pritchard JK, Rosenberg NA 1999 Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65: 220228.
  • 128
    Orwoll ES, Belknap JK, Klein RF, Duncan EL, Cardon LR, Sinsheimer JS, Wass JA, Brown MA 2001 Gender specificity in the genetic determinants of peak bone mass site and gender specificity of inheritance of bone mineral density. J Bone Miner Res 16: 19621971.
  • 129
    Duncan EL, Cardon LR, Sinsheimer JS, Wass JA, Brown MA 2003 Site and gender specificity of inheritance of bone mineral density. J Bone Miner Res 18: 15311538.
  • 130
    Harris M, Nguyen TV, Howard GM, Kelly PJ, Eisman JA 1998 Genetic and environmental correlations between bone formation and bone mineral density: A twin study. J Bone Miner Res 22: 141145.
  • 131
    Deng HW, Mahaney MC, Williams JT, Li J, Conway T, Davies KM, Li JL, Deng H, Recker RR 2002 Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet Epidemiol 22: 1225.
  • 132
    Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De PA, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van HW, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513523.
  • 133
    Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van EP, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 1119.
  • 134
    Heaney C, Shalev H, Elbedour K, Carmi R, Staack JB, Sheffield VC, Beier DR 1998 Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation. Hum Mol Genet 7: 14071410.
  • 135
    Deng HW, Xu FH, Conway T, Deng XT, Li JL, Davies KM, Deng H, Johnson M, Recker RR 2001 Is population bone mineral density variation linked to the marker D11S987 on chromosome 11q12–13? J Clin Endocrinol Metab 86: 37353741.
  • 136
    Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960974.
  • 137
    Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, Haynatzki GR, Babij P, Allen KM, Yaworsky PJ, Bex F, Recker RR 2004 Bone biomechanical properties in LRP5 mutant mice. Bone 35: 162169.
  • 138
    Ezura Y, Urano T, Nakajima T, Sudo Y, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Emi M 2004 Association of single nucleotide polymorphisms in the low density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density of adult women. J Bone Miner Res 19: S247.
  • 139
    Mizuguchi T, Furuta I, Watanabe Y, Tsukamoto K, Tomita H, Tsujihata M, Ohta T, Kishino T, Matsumoto N, Minakami H, Niikawa N, Yoshiura K 2004 LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. J Hum Genet 49: 8086.
  • 140
    Oakley JI, Moffett SP, Petro N, Cauley JA, Beck TJ, Bunker CH, Patrick AL, Wheeler VW, Ferrell RE, Zmuda JM 2004 LRP5 amino acid substitutions: Differences in allele frequencies and association with bone density and structure in Afro-Caribbean men. J Bone Miner Res 19: S387.
  • 141
    Urano T, Shiraki M, Ezura Y, Fujita M, Sekine E, Hoshino S, Hosoi T, Orimo H, Emi M, Ouchi Y, Inoue S 2004 Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J Bone Miner Metab 22: 341345.
  • 142
    Econs MJ, Koller DL, Hui SL, Fishburn T, Conneally PM, Johnston CC Jr, Peacock M, Foroud TM 2004 Confirmation of linkage to chromosome 1q for peak vertebral bone mineral density in premenopausal white women. Am J Hum Genet 74: 223228.
  • 143
    Huang QY, Xu FH, Shen H, Deng HY, Conway T, Liu YJ, Liu YZ, Li JL, Li MX, Davies KM, Recker RR, Deng HW 2004 Genome scan for QTLs underlying bone size variation at 10 refined skeletal sites: Genetic heterogeneity and the significance of phenotype refinement. Physiol Genomics 17: 326331.
  • 144
    Kammerer CM, Schneider JL, Cole SA, Hixson JE, Samollow PB, O'Connell JR, Perez R, Dyer TD, Almasy L, Blangero J, Bauer RL, Mitchell BD 2003 Quantitative trait loci on chromosomes 2p, 4p, and 13q influence bone mineral density of the forearm and hip in Mexican Americans. J Bone Miner Res 18: 22452252.
  • 145
    Karasik D, Cupples LA, Hannan MT, Kiel DP 2003 Age, gender, and body mass effects on quantitative trait loci for bone mineral density: The Framingham Study. Bone 33: 308316.
  • 146
    Karasik D, Cupples LA, Hannan MT, Kiel DP 2004 Genome screen for a combined bone phenotype using principal component analysis: The Framingham study. Bone 34: 547556.
  • 147
    Koller DL, White KE, Liu G, Hui SL, Conneally PM, Johnston CC, Econs MJ, Foroud T, Peacock M 2003 Linkage of structure at the proximal femur to chromosomes 3, 7, 8, and 19. J Bone Miner Res 18: 10571065.
  • 148
    Peacock M, Koller DL, Hui S, Johnston CC, Foroud T, Econs MJ 2004 Peak bone mineral density at the hip is linked to chromosomes 14q and 15q. Osteoporos Int 15: 489496.
  • 149
    Shen H, Zhang YY, Long JR, Xu FH, Liu YZ, Xiao P, Zhao LJ, Xiong DH, Liu YJ, Dvornyk V, Rocha-Sanchez S, Liu PY, Li JL, Conway T, Davies KM, Recker RR, Deng HW 2004 A genome-wide linkage scan for bone mineral density in an extended sample: Evidence for linkage on 11q23 and Xq27. J Med Genet 41: 743751.
  • 150
    Styrkarsdottir U, Cazier JB, Kong A, Rolfsson O, Larsen H, Bjarnadottir E, Johannsdottir VD, Sigurdardottir MS, Bagger Y, Christiansen C, Reynisdottir I, Grant SF, Jonasson K, Frigge ML, Gulcher JR, Sigurdsson G, Stefansson K 2003 Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 1: E69.
  • 151
    Wilson SG, Reed PW, Andrew T, Barber MJ, Lindersson M, Langdown M, Thompson D, Thompson E, Bailey M, Chiano M, Kleyn PW, Spector TD 2004 A genome-screen of a large twin cohort reveals linkage for quantitative ultrasound of the calcaneus to 2q33–37 and 4q12–21. J Bone Miner Res 19: 270277.
  • 152
    Huang QY, Xu FH, Shen H, Zhao LJ, Deng HY, Liu YJ, Dvomyk V, Conway T, Davies KM, Li JL, Liu YZ, Recker RR, Deng HW 2004 A second-stage genome scan for QTLs influencing BMD variation. Calcif Tissue Int 75: 138143.
  • 153
    Xu FH, Liu YJ, Deng H, Huang QY, Zhao LJ, Shen H, Liu YZ, Dvornyk V, Conway T, Li JL, Davies KM, Recker RR, Deng HW 2004 A follow-up linkage study for bone size variation in an extended sample. Bone 35: 777784.
  • 154
    Deng HW, Shen H, Xu FH, Deng H, Conway T, Liu YJ, Liu YZ, Li JL, Huang QY, Davies KM, Recker RR 2003 Several genomic regions potentially containing QTLs for bone size variation were identified in a whole-genome linkage scan. Am J Med Genet A 119: 121131.
  • 155
    Deng HW, Xu FH, Huang QY, Shen H, Deng H, Conway T, Liu YJ, Liu YZ, Li JL, Zhang HT, Davies KM, Recker RR 2002 A whole-genome linkage scan suggests several genomic regions potentially containing quantitative trait Loci for osteoporosis. J Clin Endocrinol Metab 87: 51515159.
  • 156
    Karasik D, Myers RH, Cupples LA, Hannan MT, Gagnon DR, Herbert A, Kiel DP 2002 Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: The Framingham Study. J Bone Miner Res 17: 17181727.
  • 157
    Koller DL, Liu G, Econs MJ, Hui SL, Morin PA, Joslyn G, Rodriguez LA, Conneally PM, Christian JC, Johnston CC Jr, Foroud T, Peacock M 2001 Genome screen for quantitative trait loci underlying normal variation in femoral structure. J Bone Miner Res 16: 985991.
  • 158
    Koller DL, Econs MJ, Morin PA, Christian JC, Hui SL, Parry P, Curran ME, Rodriguez LA, Conneally PM, Joslyn G, Peacock M, Johnston CC, Foroud T 2000 Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. J Clin Endocrinol Metab 85: 31163120.
  • 159
    Devoto M, Shimoya K, Caminis J, Ott J, Tenenhouse A, Whyte MP, Sereda L, Hall S, Considine E, Williams CJ, Tromp G, Kuivaniemi H, la-Kokko L, Prockop DJ, Spotila LD 1998 First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet 6: 151157.
  • 160
    Klein RF, Mitchell SR, Phillips TJ, Belknap JK, Orwoll ES 1998 Quantitative trait loci affecting peak bone mineral density in mice. J Bone Miner Res 13: 16481656.
  • 161
    Wilson SG, Reed PW, Andrew T, Langdown M, Prince RL, Spector TD 2004 Fine mapping provides further evidence of linkage for bone mineral density to 3p21. J Bone Miner Res 19: S154.
  • 162
    Wilson SG, Reed PW, Bansal A, Chiano M, Lindersson M, Langdown M, Prince RL, Thompson D, Thompson E, Bailey M, Kleyn PW, Sambrook P, Shi MM, Spector TD 2003 Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am J Hum Genet 72: 144155.
  • 163
    Koller DL, Hui SL, Johnston CC, Econs MJ, Foroud T, Peacock M 2004 Genome screen for femoral structure QTLs in men. J Bone Miner Res. 19: S156.
  • 164
    Czerwinski SA, Lee M, Choh AC, Demerath EW, Chumlea WC, Sun SS, Siervogel RM, Towne B 2004 Genome-wide scan for QTL underlying normal variation in calcaneal quantitative ultrasound measures: The Fels Longitudinal Study. J Bone Miner Res 19: S157.
  • 165
    Shimizu M, Higuchi K, Bennett B, Xia C, Tsuboyama T, Kasai S, Chiba T, Fujisawa H, Kogishi K, Kitado H, Kimoto M, Takeda N, Matsushita M, Okumura H, Serikawa T, Nakamura T, Johnson TE, Hosokawa M 1999 Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain. Mamm Genome 10: 8187.
  • 166
    Benes H, Weinstein RS, Zheng W, Thaden JJ, Jilka RL, Manolagas SC, Shmookler Reis RJ 2000 Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J Bone Miner Res 15: 626633.
  • 167
    Klein OF, Carlos AS, Vartanian KA, Chambers VK, Turner EJ, Phillips TJ, Belknap JK, Orwoll ES 2001 Confirmation and fine mapping of chromosomal regions influencing peak bone mass in mice. J Bone Miner Res 16: 19531961.
  • 168
    Beamer WG, Shultz KL, Churchill GA, Frankel WN, Baylink DJ, Rosen CJ, Donahue LR 1999 Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome 10: 10431049.
  • 169
    Beamer WG, Shultz KL, Donahue LR, Churchill GA, Sen S, Wergedal JR, Baylink DJ, Rosen CJ 2001 Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res 16: 11951206.
  • 170
    Klein RF, Allard J, Avnur Z, Nikolcheva T, Rotstein D, Carlos AS, Shea M, Waters RV, Belknap JK, Peltz G, Orwoll ES 2004 Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303: 229232.
  • 171
    Shultz KL, Donahue LR, Bouxsein ML, Baylink DJ, Rosen CJ, Beamer WG 2003 Congenic strains of mice for verification and genetic decomposition of quantitative trait loci for femoral bone mineral density. J Bone Miner Res 18: 175185.
  • 172
    Turner CH, Sun Q, Schriefer J, Pitner N, Price R, Bouxsein ML, Rosen CJ, Donahue LR, Shultz KL, Beamer WG 2003 Congenic mice reveal sex-specific genetic regulation of femoral structure and strength. Calcif Tissue Int 73: 297303.
  • 173
    Koller DL, Schriefer J, Sun Q, Shultz KL, Donahue LR, Rosen CJ, Foroud T, Beamer WG, Turner CH 2003 Genetic effects for femoral biomechanics, structure, and density in C57BL/6J and C3H/HeJ inbred mouse strains. J Bone Miner Res 18: 17581765.
  • 174
    Volkman SK, Galecki AT, Burke DT, Paczas MR, Moalli MR, Miller RA, Goldstein SA 2003 Quantitative trait loci for femoral size and shape in a genetically heterogeneous mouse population. J Bone Miner Res 18: 14971505.
  • 175
    Volkman SK, Galecki AT, Burke DT, Miller RA, Goldstein SA 2004 Quantitative trait loci that modulate femoral mechanical properties in a genetically heterogeneous mouse population. J Bone Miner Res 19: 14971505.
  • 176
    Bouxsein ML, Uchiyama T, Rosen CJ, Shultz KL, Donahue LR, Turner CH, Sen S, Churchill GA, Muller R, Beamer WG 2004 Mapping quantitative trait loci for vertebral trabecular bone volume fraction and microarchitecture in mice. J Bone Miner Res 19: 587599.
  • 177
    Masinde GL, Wergedal J, Davidson H, Mohan S, Li R, Li X, Baylink DJ 2003 Quantitative trait loci for periosteal circumference (PC): Identification of single loci and epistatic effects in F2 MRL/SJL mice. Bone 32: 554560.
  • 178
    Robling AG, Li J, Shultz KL, Beamer WG, Turner CH 2003 Evidence for a skeletal mechanosensitivity gene on mouse chromosome 4. FASEB J 17: 324326.
  • 179
    Srivastava AK, Masinde G, Yu H, Baylink DJ, Mohan S 2004 Mapping quantitative trait loci that influence blood levels of alkaline phosphatase in MRL/MpJ and SJL/J mice. Bone 35: 10861094.
  • 180
    Mohan S, Masinde G, Li X, Baylink DJ 2003 Mapping quantitative trait loci that influence serum insulin-like growth factor binding protein-5 levels in F2 mice (MRL/MpJ X SJL/J). Endocrinology 144: 34913496.
  • 181
    Lockhart DJ, Winzeler EA 2000 Genomics, gene expression and DNA arrays. Nature 405: 827836.
  • 182
    Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW 1997 Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94: 21502155.
  • 183
    Chiba S, Un-No M, Neer RM, Okada K, Serge GV, Lee K 2002 Parathyroid hormone induces interleukin-6 gene expression in bone stromal cells of young rats. J Vet Med Sci 64: 641644.
  • 184
    Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR 2002 GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31: 1920.
  • 185
    Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, Coffey E, Dai H, He YD, Kidd MJ, King AM, Meyer MR, Slade D, Lum PY, Stepaniants SB, Shoemaker DD, Gachotte D, Chakraburtty K, Simon J, Bard M, Friend SH 2000 Functional discovery via a compendium of expression profiles. Cell 102: 109126.
  • 186
    Liu F, Aubin JE, Malaval L 2002 Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: Differential regulation by dexamethasone and LIF. Bone 31: 212219.
  • 187
    Power RA, Iwaniec UT, Wronski TJ 2002 Changes in gene expression associated with the bone anabolic effects of basic fibroblast growth factor in aged ovariectomized rats. Bone 31: 143148.
  • 188
    Srivastava S, Weitzmann MN, Kimble RB, Rizzo M, Zahner M, Milbrandt J, Ross FP, Pacifici R 1998 Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest 102: 18501859.
  • 189
    Tomlinson JW, Bujalska I, Stewart PM, Cooper MS 2000 The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocr Res 26: 711722.
  • 190
    Locklin RM, Riggs BL, Hicok KC, Horton HF, Byrne MC, Khosla S 2001 Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology. J Bone Miner Res 16: 21922204.
  • 191
    Chen J, Zhong Q, Wang J, Cameron RS, Borke JL, Isales CM, Bollag RJ 2001 Microarray analysis of Tbx2-directed gene expression: A possible role in osteogenesis. Mol Cell Endocrinol 177: 4354.
  • 192
    Beck GR Jr, Zerler B, Moran E 2001 Gene array analysis of osteoblast differentiation. Cell Growth Differ 12: 6183.
  • 193
    Connor JR, Kumar S, Sathe G, Mooney J, O'Brien SP, Mui P, Murdock PR, Gowen M, Lark MW 2001 Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthritis Cartilage 9: 727737.
  • 194
    Stokes DG, Liu G, Coimbra IB, Piera-Velazquez S, Crowl RM, Jimenez SA 2002 Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 46: 404419.
  • 195
    Vincenti MP, Brinckerhoff CE 2001 Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res 3: 381388.
  • 196
    Furushima K, Shimo-Onoda K, Maeda S, Nobukuni T, Ikari K, Koga H, Komiya S, Nakajima T, Harata S, Inoue I 2002 Large-scale screening for candidate genes of ossification of the posterior longitudinal ligament of the spine. J Bone Miner Res 17: 128137.
  • 197
    Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, Trepel J, Meltzer P, Helman L 2001 Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 61: 37503759.
  • 198
    Shi S, Robey PG, Gronthos S 2001 Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis. Bone 29: 532539.
  • 199
    Theilhaber J, Connolly T, Roman-Roman S, Bushnell S, Jackson A, Call K, Garcia T, Baron R 2002 Finding genes in the C2C12 osteogenic pathway by k-nearest-neighbor classification of expression data. Genome Res 12: 165176.
  • 200
    Gu W, Li X, Lau KH, Edderkaoui B, Donahae LR, Rosen CJ, Beamer WG, Shultz KL, Srivastava A, Mohan S, Baylink DJ 2002 Gene expression between a congenic strain that contains a quantitative trait locus of high bone density from CAST/EiJ and its wild-type strain C57BL/6J. Funct Integr Genomics 1: 375386.
  • 201
    Doi M, Nagano A, Nakamura Y 2002 Genome-wide screening by cDNA microarray of genes associated with matrix mineralization by human mesenchymal stem cells in vitro. Biochem Biophys Res Commun 290: 381390.
  • 202
    Raouf A, Seth A 2002 Discovery of osteoblast-associated genes using cDNA microarrays. Bone 30: 463471.
  • 203
    Bianco P, Riminucci M, Gronthos S, Robey PG 2001 Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19: 180192.
  • 204
    Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG 1997 Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63: 10591069.
  • 205
    Takahashi N, Udagawa NT, Takami M 2002 Cells of bone: Osteoclast generation. BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, USA, 109126.
  • 206
    Liu YZ, Dvornyk V, Liu YJ, Shen H, Chang J, Recker R, Deng HW 2004 Microarray study of circulating monocytes in search for functional genes for osteoporosis. J Bone Miner Res 19: S150.
  • 207
    Kamme F, Erlander MG 2003 Global gene expression analysis of single cells. Curr Opin Drug Discov Devel 6: 231236.
  • 208
    Kamme F, Salunga R, Yu J, Tran DT, Zhu J, Luo L, Bittner A, Guo HQ, Miller N, Wan J, Erlander M 2003 Single-cell microarray analysis in hippocampus CA1: Demonstration and validation of cellular heterogeneity. J Neurosci 23: 36073615.
  • 209
    Sanz E, Alvarez-Mon M, Martinez-A C, de la Hera A 2003 Human cord blood CD34+Pax-5+ B-cell progenitors: Single-cell analyses of their gene expression profiles. Blood 101: 34243430.
  • 210
    Abbott A 1999 A post-genomic challenge: Learning to read patterns of protein synthesis. Nature 402: 715720.
  • 211
    Anderson L, Seilhamer J 1997 A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533537.
  • 212
    Gygi SP, Rochon Y, Franza BR, Aebersold R 1999 Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19: 17201730.
  • 213
    Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, Bumgarner R, Goodlett DR, Aebersold R, Hood L 2001 Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292: 929934.
  • 214
    Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, Selby PJ 2000 Proteomics: New perspectives, new biomedical opportunities. Lancet 356: 17491756.
  • 215
    Graves PR, Haystead TA 2002 Molecular biologist's guide to proteomics. Microbiol Mol Biol Rev 66: 3963.
  • 216
    Blackstock WP, Weir MP 1999 Proteomics: Quantitative and physical mapping of cellular proteins. Trends Biotechnol 17: 121127.
  • 217
    Evans CA, Tonge R, Blinco D, Pierce A, Shaw J, Lu Y, Hamzah HG, Gray A, Downes CP, Gaskell SJ, Spooncer E, Whetton AD 2004 Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility. Blood 103: 37513759.
  • 218
    Brown RE, Boyle JL 2003 Mesenchymal chondrosarcoma: Molecular characterization by a proteomic approach, with morphogenic and therapeutic implications. Ann Clin Lab Sci 33: 131141.
  • 219
    Behnam K, Murray SS, Whitelegge JP, Brochmann EJ 2002 Identification of the molecular chaperone alpha B-crystallin in demineralized bone powder and osteoblast-like cells. J Orthop Res 20: 11901196.
  • 220
    Kubota K, Wakabayashi K, Matsuoka T 2003 Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: Two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography. Proteomics 3: 616626.
  • 221
    Nuttall ME 2001 Drug discovery and target validation. Cells Tissues Organs 169: 265271.
  • 222
    Lorenz P, Ruschpler P, Koczan D, Stiehl P, Thiesen HJ 2003 From transcriptome to proteome: Differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies. Proteomics 3: 9911002.
  • 223
    Liu XH, Liu YJ, Jiang DK, Li YM, Li MX, Qin YJ, Jian WX, Zhou Q, Deng HW 2003 No evidence for linkage and/or association of human alpha2-HS glycoprotein gene with bone mineral density variation in Chinese nuclear families. Calcif Tissue Int 73: 244250.
  • 224
    Schoofs MW, van der KM, Hofman A, van Duijn CM, Stricker BH, Pols HA, Uitterlinden AG 2004 ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: The Rotterdam study. J Bone Miner Res 19: 14901496.
  • 225
    Efstathiadou Z, Koukoulis G, Stakias N, Challa A, Tsatsoulis A 2004 Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women. Maturitas 48: 259264.
  • 226
    Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Maenpaa PH 2003 Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial. J Bone Miner Res 18: 319324.
  • 227
    Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF 2003 A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Calcif Tissue Int 73: 237243.
  • 228
    Chen HY, Chen WC, Wu MC, Tsai FJ, Tsai CH 2003 Androgen receptor (AR) gene microsatellite polymorphism in postmenopausal women: Correlation to bone mineral density and susceptibility to osteoporosis. Eur J Obstet Gynecol Reprod Biol 107: 5256.
  • 229
    Ebeling PR, Hussein Z, Ellis J, Lamantia A, Greenland K, Yeung S, Wong Z, Zajac JD, Harrap S 2004 Androgen receptor CAG repeat polymorphism and bone density: A family and case-control association study in men with primary osteoporosis. J Bone Miner Res 19: S380.
  • 230
    Kenny AM, McGee D, Joseph C, Abreu C, Raisz LG 2004 Lack of association between androgen receptor polymorphisms and bone mineral density or physical function in older men. J Bone Miner Res 19: S381.
  • 231
    Mo XY, Cao CK, Xu FH, Liu MY, Li MX, Qin YJ, Zhou Q, Zhang YY, Deng HW 2004 Lack of association between the HindIII RFLP of the osteocalcin (BGP) gene and bone mineral density (BMD) in healthy pre- and postmenopausal Chinese women. J Bone Miner Metab 22: 264269.
  • 232
    Ichikawa S, Koller DL, Johnson ML, Lai D, Johnston CC, Hui SL, Foroud TM, Peacock M, Econs MJ 2004 Polymorphisms in the bone morphogenetic protein 2 (BMP2) gene do not affect peak bone mineral density in men and women. J Bone Miner Res 19: S249.
  • 233
    Cetani F, Pardi E, Borsari S, Vignali E, Dipollina G, Braga V, Adami S, Pinchera A, Marcocci C 2003 Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women. Eur J Endocrinol 148: 603607.
  • 234
    Young R, Wu F, Van de Water N, Ames R, Gamble G, Reid IR 2003 Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal women. J Clin Endocrinol Metab 88: 697700.
  • 235
    Takacs I, Speer G, Bajnok E, Tabak A, Nagy Z, Horvath C, Kovacs K, Lakatos P 2002 Lack of association between calcium-sensing receptor gene “A986S” polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 30: 849852.
  • 236
    Bajnok E, Lakatos G, Tabak A, Takacs I, Horvath C, Kosa J, Speer G, Madarasz E, Nagy Z, Lakatos P 2004 Association between collagen type I alpha1 (COL1A1) gene Sp1-, calcium-sensing receptor (CaSR) gene A986S-, interleukin-1 receptor antagonist (IL-1LN) gene VNTR polymorphisms and osteoporosis; their impact in prediction of osteoporotic bone fracture. J Bone Miner Res 19: S384.
  • 237
    Kim J, Ku S, Suh C, Kim S, Choi Y, Moon S 2004 Relationship among calcium sensing receptor gene (CA) polymorphism, bone mineral density and bone responsiveness to hormone replacement therapy in postmenopausal Korean women. J Bone Miner Res 19: S245.
  • 238
    Balcells S, Bustamante M, Enjuanes A, Garcia-Giralt N, Aymar I, Nogu X, Mellibovsky L, Grinberg D 2004 COL1A1, but not ESR1 or VDR polymorphisms are associated with BMD in a cohort of Spanish postmenopausal women. J Bone Miner Res 19: S249.
  • 239
    Willing MC, Torner JC, Burns TL, Janz KF, Marshall T, Gilmore J, Deschenes SP, Warren JJ, Levy SM 2003 Gene polymorphisms, bone mineral density and bone mineral content in young children: The Iowa Bone Development Study. Osteoporos Int 14: 650658.
  • 240
    van der Sluis IM, de Muinck Keizer-Schrama SM, Krenning EP, Pols HA, Uitterlinden AG 2003 Vitamin D receptor gene polymorphism predicts height and bone size, rather than bone density in children and young adults. Calcif Tissue Int 73: 332338.
  • 241
    Sapir-Koren R, Livshits G, Kobyliansky E 2003 Association and linkage disequilibrium analyses suggest genetic effects of estrogen receptor alpha and collagen IA1 genes on bone mineral density in Caucasian women. Calcif Tissue Int 72: 643650.
  • 242
    Pluijm SM, van Essen HW, Bravenboer N, Uitterlinden AG, Smit JH, Pols HA, Lips P 2004 Collagen type I alpha1 Sp1 polymorphism, osteoporosis, and intervertebral disc degeneration in older men and women. Ann Rheum Dis 63: 7177.
  • 243
    Alvarez-Hernandez D, Naves M, Diaz-Lopez JB, Gomez C, Santamaria I, Cannata-Andia JB 2003 Influence of polymorphisms in VDR and COLIA1 genes on the risk of osteoporotic fractures in aged men. Kidney Int 85: S14S18.
  • 244
    van der Sluis IM, de Muinck Keizer-Schrama SM, Pols HA, Lequin MH, Krenning EP, Uitterlinden AG 2002 Collagen Ialpha1 polymorphism is associated with bone characteristics in Caucasian children and young adults. Calcif Tissue Int 71: 393399.
  • 245
    Barros ER, Kasamatsu TS, Ramalho AC, Hauache OM, Vieira JG, Lazaretti-Castro M 2002 Bone mineral density in young women of the city of Sao Paulo, Brazil: Correlation with both collagen type I alpha 1 gene polymorphism and clinical aspects. Braz J Med Biol Res 35: 885893.
  • 246
    Kann P, Bergink AP, Fang Y, Van Daele PL, Hofman A, van Leeuwen JP, Beyer J, Uitterlinden AG, Pols HA 2002 The collagen Ia1 SP1 polymorphism is associated with differences in ultrasound transmission velocity in the calcaneus in postmenopausal women. Calcif Tissue Int 70: 450456.
  • 247
    Liu PY, Lu Y, Long JR, Xu FH, Shen H, Recker RR, Deng HW 2004 Common variants at the PCOL2 and Sp1 binding sites of the COL1A1 gene and their interactive effect influence bone mineral density in Caucasians. J Med Genet 41: 752757.
  • 248
    Long JR, Liu PY, Lu Y, Dvornyk V, Xiong DH, Zhao LJ, Deng HW 2005 Tests of linkage and/or association of TGF-beta1 and COL1A1 genes with bone mass. Osteoporos Int 16: 8692.
  • 249
    Lau EM, Choy DT, Li M, Woo J, Chung T, Sham A 2004 The relationship between COLI A1 polymorphisms (Sp 1) and COLI A2 polymorphisms (Eco R1 and Puv II) with bone mineral density in Chinese men and women. Calcif Tissue Int 75: 133137.
  • 250
    Deng FY, Liu MY, Li MX, Lei SF, Qin YJ, Zhou Q, Liu YJ, Deng HW 2003 Tests of linkage and association of the COL1A2 gene with bone phenotypes' variation in Chinese nuclear families. Bone 33: 614619.
  • 251
    Suuriniemi M, Mahonen A, Lyytikainen A, Kovanen V, Alen M, Cheng S 2004 Faster bone growth during puberty contributed by the COL1A2 polymorphism: A benefit or risk? J Bone Miner Res 19: S383.
  • 252
    Tofteng CL, Abrahamsen B, Jensen JE, Petersen S, Teilmann J, Kindmark A, Vestergaard P, Gram J, Langdahl BL, Mosekilde L 2004 Two single nucleotide polymorphisms in the CYP17 and COMT Genes–relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study. Calcif Tissue Int 75: 123132.
  • 253
    Lorentzon M, Eriksson AL, Mellstrom D, Ohlsson C 2004 The COMT val158met polymorphism is associated with peak BMD in men. J Bone Miner Res 19: 20052011.
    Direct Link:
  • 254
    Zofkova I, Zajickova K, Hill M, Krepelova A 2003 Does polymorphism C1377T of the calcitonin receptor gene determine bone mineral density in postmenopausal women? Exp Clin Endocrinol Diabetes 111: 447449.
  • 255
    Kim JG, Choi YM, Moon SY, Lee JY 2003 Association of the calcitonin gene (CA) polymorphism with bone mass and bone responsiveness to hormone therapy in postmenopausal Korean women. Menopause 10: 544549.
  • 256
    Tsai FJ, Chen WC, Chen HY, Tsai CH 2003 The ALUI calcitonin receptor gene polymorphism (TT) is associated with low bone mineral density and susceptibility to osteoporosis in postmenopausal women. Gynecol Obstet Invest 55: 8287.
  • 257
    Braga V, Sangalli A, Malerba G, Mottes M, Mirandola S, Gatti D, Rossini M, Zamboni M, Adami S 2002 Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men. Calcif Tissue Int 70: 457462.
  • 258
    Somner J, McLellan S, Cheung J, Mak YT, Frost ML, Knapp KM, Wierzbicki AS, Wheeler M, Fogelman I, Ralston SH, Hampson GN 2004 Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: Association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 89: 344351.
  • 259
    Zarrabeitia MT, Hernandez JL, Valero C, Zarrabeitia AL, Garcia-Unzueta M, Amado JA, Gonzalez-Macias J, Riancho JA 2004 A common polymorphism in the 5′-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur J Endocrinol 150: 699704.
  • 260
    Gennari L, Masi L, Merlotti D, Picariello L, Falchetti A, Tanini A, Mavilia C, Del Monte F, Gonnelli S, Lucani B, Gennari C, Brandi ML 2004 A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: Effects on bone metabolism. J Clin Endocrinol Metab 89: 28032810.
  • 261
    Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Maenpaa PH 2003 Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women. Ann Med 35: 282288.
  • 262
    Van Pottelbergh I, Goemaere S, Kaufman JM 2003 Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 88: 30753081.
  • 263
    Lorentzon M, Swanson C, Erikson A, Ohlsson C 2004 Aromatase CYP19 genetic polymorphism is associated with adult stature, androgen levels, and bone mineral density in 18–20-year-old Swedish males. J Bone Miner Res 19: S382.
  • 264
    Al-oanzi ZH, Tuck SP, Varanasi SS, Raj N, Harrop JS, Summers GD, Cook DB, Francis RM, Datta HK 2004 (TAAA)(n)-Alu element polymorphism in vitamin D binding protein gene and its association with bone density and osteoporosis in men. J Bone Miner Res 19: S249.
  • 265
    Ongphiphadhanakul B, Chanprasertyothin S, Payattikul P, Saetung S, Rajatanavin R 2003 The implication of assessing a polymorphism in estrogen receptor alpha gene in the risk assessment of osteoporosis using a screening tool for osteoporosis in Asians. Osteoporos Int 14: 863867.
  • 266
    Fountas L, Anapliotou M, Kominakis A, Sekeris CE, Kassi E, Moutsatsou P 2004 Estrogen receptor alpha gene analysis in osteoporosis and familial osteoporosis. Osteoporos Int 15: 948956.
  • 267
    Allcroft LC, Varanasi SS, Dimopoulos D, Francis RM, Datta HK 2002 Mutational and polymorphic analysis of the estradiol receptor-alpha gene in men with symptomatic vertebral fractures. Calcif Tissue Int 71: 400405.
  • 268
    Zmuda JM, Cauley JA, Lui L, Greene DR, Li J, Walker K, Stone KL, Ensrud KE, Hillier TA, Peltz G, Cummings SR 2004 Estrogen receptor-a genotype and hip fracture risk in older women: Evidence for a strong interaction with body mass index. J Bone Miner Res 19: S387.
  • 269
    Suuriniemi M, Mahonen A, Kovanen V, Alen M, Lyytikainen A, Wang Q, Kroger H, Cheng S 2004 Association between exercise and pubertal BMD is modulated by estrogen receptor alpha genotype. J Bone Miner Res 19: 17581765.
  • 270
    Long JR, Zhang YY, Liu PY, Liu YJ, Shen H, Dvornyk V, Zhao LJ, Deng HW 2004 Association of estrogen receptor alpha and vitamin D receptor gene polymorphisms with bone mineral density in Chinese males. Calcif Tissue Int 74: 270276.
  • 271
    Sapir-Koren R, Livshits G, Kobyliansky E 2003 Genetic effects of estrogen receptor alpha and collagen IA1 genes on the relationships of parathyroid hormone and 25 hydroxyvitamin D with bone mineral density in Caucasian women. Metabolism 52: 11291135.
  • 272
    Zhang YY, Long JR, Liu PY, Liu YJ, Shen H, Zhao LJ, Deng HW 2003 Estrogen receptor alpha and vitamin D receptor gene polymorphisms and bone mineral density: Association study of healthy pre- and postmenopausal Chinese women. Biochem Biophys Res Commun 308: 777783.
  • 273
    Khosla S, Riggs BL, Atkinson EJ, Oberg AL, Mavilia C, Del Monte F, Melton LJ III, Brandi ML 2004 Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. J Clin Endocrinol Metab 89: 18081816.
  • 274
    Liu J, Zhu H, Zhu X, Dai M, Jiang L, Xu M, Chen J 2003 Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women. Chin Med J (Engl) 116: 364367.
  • 275
    Boot AM, van der Sluis IM, de Muinck Keizer-Schrama SM, van Meurs JB, Krenning EP, Pols HA, Uitterlinden AG 2004 Estrogen receptor alpha gene molymorphisms and bone mineral density in healthy children and young adults. Calcif Tissue Int 74: 495500.
  • 276
    Koh JM, Nam-Goong IS, Hong JS, Kim HK, Kim JS, Kim SY, Kim GS 2004 Oestrogen receptor alpha genotype, and interactions between vitamin D receptor and transforming growth factor-beta1 genotypes are associated with quantitative calcaneal ultrasound in postmenopausal women. Clin Endocrinol (Oxf) 60: 232240.
  • 277
    Matsushita H, Kurabayashi T, Tomita M, Tanaka K 2004 Effects of vitamin D and estrogen receptor gene polymorphisms on the changes in lumbar bone mineral density with multiple pregnancies in Japanese women. Hum Reprod 19: 5964.
  • 278
    Valimaki VV, Piippo K, Valimaki S, Loyttyniemi E, Kontula K, Valimaki MJ 2004 Relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men. J Bone Miner Res 19: S247.
  • 279
    Masi L, Ottanelli S, Del Monte F, Carbonell S, Guazzini L, Fossi N, Gozzini A, Mavilla C, Falchetti A, Imbriaco R, Tanini A, Brandi ML 2004 Aromatase and estrogen receptor alpha gene polymorhpisms: Response of the bone mineral density in post-menopausal women to HRT. J Bone Miner Res 19: S248S249.
  • 280
    Zhang Z, Qin Y, Huang Q, He J, Li M, Zhou Q, Liu Y, Hu H 2004 Association of estrogen receptor-alpha and vitamin D receptor genotypes with therapeutic response to calcium in postmenopausal Chinese women. J Bone Miner Res 19: S246.
  • 281
    Kung AWC, Lau HHL, Paterson AD, Cheung WMW, Luk KDK, Chan V 2004 Test of linkage and/or association of genes and bone mineral density in Chinese. J Bone Miner Res 19: S243.
  • 282
    Scariano JK, Simplicio SG, Montoya GD, Garry PJ, Baumgartner RN 2004 Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcif Tissue Int 74: 501508.
  • 283
    Lau HH, Ho AY, Luk KD, Kung AW 2002 Estrogen receptor beta gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women. Bone 31: 276281.
  • 284
    Arko B, Prezelj J, Komel R, Kocijancic A, Marc J 2002 No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis. J Steroid Biochem Mol Biol 81: 147152.
  • 285
    Liu X, Rosen C, Mora S, Dong D, Pitukcheewanont P, Gilsanz V 2004 Low DXA and CT bone measures in young adults with a simple sequence repeat in IGF-I gene. J Bone Miner Res 19: S248.
  • 286
    Han KO, Choi JT, Moon IG, Jeong MS, Yim CH, Chung HY, Jang HC, Yoon HK, Han IK 2002 Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women. Bone 31: 612615.
  • 287
    Nordstrom A, Gerdhem P, Brandstrom H, Stiger F, Lerner UH, Lorentzon M, Obrant K, Nordstrom P, Akesson K 2004 Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women. Osteoporos Int 15: 820826.
  • 288
    Dhamrait SS, James L, Brull DJ, Myerson S, Hawe E, Pennell DJ, World M, Humphries SE, Haddad F, Montgomery HE 2003 Cortical bone resorption during exercise is interleukin-6 genotype-dependent. Eur J Appl Physiol 89: 2125.
  • 289
    Chung HW, Seo JS, Hur SE, Kim HL, Kim JY, Jung JH, Kim LH, Park BL, Shin HD 2003 Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet 48: 243248.
  • 290
    Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL 2003 Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88: 255259.
  • 291
    Ishida R, Emi M, Ezura Y, Iwasaki H, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Ito H, Orimo H 2003 Association of a haplotype (196Phe/532Ser) in the interleukin-1-receptor-associated kinase (IRAK1) gene with low radial bone mineral density in two independent populations. J Bone Miner Res 18: 419423.
  • 292
    Ogata N, Matsumura Y, Shiraki M, Kawano K, Koshizuka Y, Hosoi T, Nakamura K, Kuro O, Kawaguchi H 2002 Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone 31: 3742.
  • 293
    Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL, Ralston SH, Compston JE, Cooper C, Keen R, Langdahl BL, MacLelland A, O'Riordan J, Pols HA, Reid DM, Uitterlinden AG, Wass JA, Brown MA 2004 Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19: 16191627.
  • 294
    Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR 2004 Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: A cross-sectional study. Bone 35: 760765.
  • 295
    Villadsen MM, Bunger MH, Carstens M, Stenkjaer L, Langdahl BL 2004 Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int 16: 411416.
  • 296
    Jorgensen HL, Madsen JS, Madsen B, Saleh MM, Abrahamsen B, Fenger M, Lauritzen JB 2002 Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women. Calcif Tissue Int 71: 386392.
  • 297
    Merlotti D, Gennari L, Martini G, Calabr A, De Paola V, Dal Canto N, Salvadori S, Valenti R, Franci B, Campagna S, Lucani B, Nuti R 2004 OPG polymorphism, serum RANKI, serum OPG and bone metabolism in men. J Bone Miner Res 19: S438.
  • 298
    Brandstrom H, Gerdhem P, Stiger F, Obrant KJ, Melhus H, Ljunggren O, Kindmark A, Akesson K 2004 Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women. Calcif Tissue Int 74: 1824.
  • 299
    Ohmori H, Makita Y, Funamizu M, Hirooka K, Hosoi T, Orimo H, Suzuki T, Ikari K, Nakajima T, Inoue I, Hata A 2002 Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. J Hum Genet 47: 400406.
  • 300
    Katsumata K, Nishizawa K, Unno A, Fujita Y, Tokita A 2002 Association of gene polymorphisms and bone density in Japanese girls. J Bone Miner Metab 20: 164169.
  • 301
    Scillitani A, Jang C, Wong B, Rubin L, Hendy G, Cole D 2004 A functional (AAAG)n polymorphism in the PTHR1 promoter is associated with height but not with BMD in a large cohort of young Caucasian women. J Bone Miner Res 19: S248.
  • 302
    Ezura Y, Kajita M, Ishida R, Yoshida S, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, Orimo H, Emi M 2004 Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women. J Bone Miner Res 19: 12961301.
  • 303
    Lau HH, Ho AY, Luk KD, Kung AW 2004 Transforming growth factor-beta1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women. Calcif Tissue Int 74: 516521.
  • 304
    Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF 2003 Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 32: 297310.
  • 305
    Tasker PN, Albagha OM, Masson CB, Reid DM, Ralston SH 2004 Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture. Osteoporos Int 15: 903908.
  • 306
    Furuta I, Kobayashi N, Fujino T, Kobamatsu Y, Shirogane T, Yaegashi M, Sakuragi N, Cho K, Yamada H, Okuyama K, Minakami H 2004 Bone mineral density of the lumbar spine is associated with TNF gene polymorphisms in early postmenopausal Japanese women. Calcif Tissue Int 74: 509515.
  • 307
    Wennberg P, Nordstrom P, Lorentzon R, Lerner UH, Lorentzon M 2002 TNF-alpha gene polymorphism and plasma TNF-alpha levels are related to lumbar spine bone area in healthy female Caucasian adolescents. Eur J Endocrinol 146: 629634.
  • 308
    Ota N, Nakajima T, Ezura Y, Iwasaki H, Suzuki T, Hosoi T, Orimo H, Inoue S, Ito H, Emi M 2002 Association of a single nucleotide variant in the human tumour necrosis factor alpha promoter region with decreased bone mineral density. Ann Hum Biol 29: 550558.
  • 309
    Qin YJ, Zhang ZL, Huang QR, He JM, Hu YQ, Zhao Q, Lu JH, Li M, Liu YJ 2004 Association of vitamin D receptor and estrogen receptor-alpha gene polymorphism with peak bone mass and bone size in Chinese women. Acta Pharmacol Sin 25: 462468.
  • 310
    Huang QR, Zhang ZL, Qin YJ, He JW, Lu JH, Zhou Q, Hu YQ, Li M, Liu YJ 2003 Association of Apa I polymorphism of vitamin D receptor gene with bone mass in men. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25: 254257.
  • 311
    Zajickova K, Zofkova I, Bahbouh R, Krepelova A 2002 Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass. Physiol Res 51: 501509.
  • 312
    Kim JG, Kwon JH, Kim SH, Choi YM, Moon SY, Lee JY 2003 Association between vitamin D receptor gene haplotypes and bone mass in postmenopausal Korean women. Am J Obstet Gynecol 189: 12341240.
  • 313
    Taguchi A, Whit SC, Kobayashi J, Survice SK, Nakamoto T, Ohtsuka M, Sanada M, Tsuda M, Ohama K, Suei Y, Tanimoto K 2004 Relationship between vitamin D receptor gene polymorphism and trabecular bone pattern of the mandible in Japanese postmenopausal wome. J Bone Miner Res 19: S245.
  • 314
    Rogers A, Clowes JA, Gossiel F, Peel NFA, Eastell R 2004 The effect of BsmI and FokI genotypes on BMD and bone turnover response to raloxifene therapy. J Bone Miner Res 19: S131.
  • 315
    Rapuri PB, Gallagher JC, Knezetic JA, Kinyamu HK, Ryschon KL 2004 Association between Vitamin D receptor polymorphisms and the rate of bone loss in elderly women-importance of adjusting for dietary and lifestyle factors. J Steroid Biochem Mol Biol 89–90: 503506.
  • 316
    Obermayer-Pietsch BM, Lange U, Tauber G, Fruhauf G, Fahrleitner A, Dobnig H, Hermann J, Aglas F, Teichmann J, Neeck G, Leb G 2003 Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis. Osteoporos Int 14: 9951000.
  • 317
    Palomba S, Numis FG, Mossetti G, Rendina D, Vuotto P, Russo T, Zullo F, Nappi C, Nunziata V 2003 Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: Relationship with BsmI vitamin D receptor genotypes. Clin Endocrinol (Oxf) 58: 365371.
  • 318
    Palomba S, Numis FG, Mossetti G, Rendina D, Vuotto P, Russo T, Zullo F, Nappi C, Nunziata V 2003 Raloxifene administration in post-menopausal women with osteoporosis: Effect of different BsmI vitamin D receptor genotypes. Hum Reprod 18: 192198.
  • 319
    Pinter B, Kocijancic A, Marc J, Andolsek-Jeras L, Prezelj J 2003 Vitamin D receptor gene polymorphism and bone metabolism during low-dose oral contraceptive use in young women. Contraception 67: 3337.
  • 320
    Laaksonen M, Karkkainen M, Outila T, Vanninen T, Ray C, Lamberg-Allardt C 2002 Vitamin D receptor gene BsmI-polymorphism in Finnish premenopausal and postmenopausal women: Its association with bone mineral density, markers of bone turnover, and intestinal calcium absorption, with adjustment for lifestyle factors. J Bone Miner Metab 20: 383390.
  • 321
    Blanchet C, Giguere Y, Prud'homme D, Dumont M, Rousseau F, Dodin S 2002 Association of physical activity and bone: Influence of vitamin D receptor genotype. Med Sci Sports Exerc 34: 2431.
  • 322
    Quesada JM, Casado A, Diaz C, Barrios L, Cuenca-Acevedo R, Dorado G 2004 Allele-frequency determination of BsmI and FokI polymorphisms of the VDR gene by quantitative real-time PCR (QRT-PCR) in pooled genomic DNA samples. J Steroid Biochem Mol Biol 89–90: 209214.
  • 323
    Douroudis K, Tarassi K, Ioannidis G, Giannakopoulos F, Moutsatsou P, Thalassinos N, Papasteriades C 2003 Association of vitamin D receptor gene polymorphisms with bone mineral density in postmenopausal women of Hellenic origin. Maturitas 45: 191197.
  • 324
    Quesada-Gomez JM, Casado A, Cuenca-Acevedo R, Barrios L, Diaz-Molina C, Dorado G 2004 The polymorphisms of the vdr cdx-2 influence bone mineral density (BMD) in postmenopausal women. J Bone Miner Res 19: S250.
  • 325
    Nakamura O, Ishii T, Ando Y, Amagai H, Oto M, Imafuji T, Tokuyama K 2002 Potential role of vitamin D receptor gene polymorphism in determining bone phenotype in young male athletes. J Appl Physiol 93: 19731979.
  • 326
    Zhang ZL, Zhao JX, Meng XW, Zhou XY, Xing XP, Xia WB 2003 Association of polymorphisms of vitamin D receptor gene start codon and 3′-end region with bone mineral density in postmenopausal women. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20: 58.
  • 327
    Laaksonen MM, Karkkainen MU, Outila TA, Rita HJ, Lamberg-Allardt CJ 2004 Vitamin D receptor gene start codon polymorphism (FokI) is associated with forearm bone mineral density and calcaneal ultrasound in Finnish adolescent boys but not in girls. J Bone Miner Metab 22: 479485.
  • 328
    Strandberg S, Nordstrom P, Lorentzon R, Lorentzon M 2003 Vitamin D receptor start codon polymorphism (FokI) is related to bone mineral density in healthy adolescent boys. J Bone Miner Metab 21: 109113.
  • 329
    Lau EM, Lam V, Li M, Ho K, Woo J 2002 Vitamin D receptor start codon polymorphism (Fok I) and bone mineral density in Chinese men and women. Osteoporos Int 13: 218221.
  • 330
    Vidal C, Grima C, Brincat M, Megally N, Xuereb-Anastasi A 2003 Associations of polymorphisms in the vitamin D receptor gene (BsmI and FokI) with bone mineral density in postmenopausal women in Malta. Osteoporos Int 14: 923928.
  • 331
    Grundberg E, Brandstrom H, Ribom EL, Ljunggren O, Kindmark A, Mallmin H 2003 A poly adenosine repeat in the human vitamin D receptor gene is associated with bone mineral density in young Swedish women. Calcif Tissue Int 73: 455462.
  • 332
    Rapuri PB, Gallagher JC, Haynatzka V 2004 Poly andenosine repeat in the human vitamin D receptor gene is associated with increased bone loss in elderly women. J Bone Miner Res 19: S246.
  • 333
    Kurabayashi T, Matsushita H, Tomita M, Kato N, Kikuchi M, Nagata H, Honda A, Yahata T, Tanaka K 2004 Association of vitamin D and estrogen receptor gene polymorphism with the effects of longterm hormone replacement therapy on bone mineral density. J Bone Miner Metab 22: 241247.
  • 334
    Duman BS, Tanakol R, Erensoy N, Ozturk M, Yilmazer S 2004 Vitamin D receptor alleles, bone mineral density and turnover in postmenopausal osteoporotic and healthy women. Med Princ Pract 13: 260266.
  • 335
    McClean E, Archbold GP, Taggart HM 2003 Do the COL1A1 and Taq 1 vitamin D receptor polymorphisms have a role in identifying individuals at risk of developing osteoporosis? Ulster Med J 72: 2633.
  • 336
    Van Pottelbergh I, Goemaere S, De Bacquer D, De Paepe A, Kaufman M 2002 Vitamin D receptor gene allelic variants, bone density, and bone turnover in community-dwelling men. Bone 31: 631637.
  • 337
    Krall EA, Fleet JC, Vokonas PS, Miller DR, Rich SE 2004 Interactions of calcium intake with FokI and androgen receptor genotypes in men. J Bone Miner Res 19: S245.
  • 338
    Zmuda JM, Cauley JA, Danielson ME, Ferrell RE 2003 Vitamin D receptor and aromatase gene interaction and bone mass in older African-American women. Metabolism 52: 521523.
  • 339
    Qin Y, Zhang Z, Huang Q, He J, Hu Y, Zhou Q, Li M, Liu Y 2004 Association of peak bone mineral density and related factors with osteoporosis in Chinese women: A case control study for daughter to mother. J Bone Miner Res 19: S242.
  • 340
    Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G 2004 Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164: 509514.
  • 341
    Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, Aihara K, Yamamoto Y, Nakamichi Y, Metzger D, Chambon P, Nakamura K, Kawaguchi H, Kato S 2003 Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 100: 94169421.
  • 342
    Nielsen KL, Allen MR, Bloomfield SA, Andersen TL, Chen XD, Poulsen HS, Young MF, Heegaard AM 2003 Biglycan deficiency interferes with ovariectomy-induced bone loss. J Bone Miner Res 18: 21522158.
  • 343
    Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, Seedor JG, Hanks MC, Amling M, Pinero GJ, Harada S, Behringer RR 2004 Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem 279: 2756027566.
  • 344
    Peng Z, Li X, Makela S, Vaananen HK, Poutanen M 2004 Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase. J Bone Miner Res 19: 13201328.
  • 345
    Lee KC, Jessop H, Suswillo R, Zaman G, Lanyon LE 2004 The adaptive response of bone to mechanical loading in female transgenic mice is deficient in the absence of oestrogen receptor-alpha and -beta. J Endocrinol 182: 193201.
  • 346
    Roschger P, Matsuo K, Misof BM, Tesch W, Jochum W, Wagner EF, Fratzl P, Klaushofer K 2004 Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1. Bone 34: 776782.
  • 347
    Kacena MA, Shivdasani RA, Wilson K, Xi Y, Troiano N, Nazarian A, Gundberg CM, Bouxsein ML, Lorenzo JA, Horowitz MC 2004 Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J Bone Miner Res 19: 652660.
  • 348
    Hamrick MW, Pennington C, Byron CD 2003 Bone architecture and disc degeneration in the lumbar spine of mice lacking GDF-8 (myostatin). J Orthop Res 21: 10251032.
  • 349
    Levasseur R, Barrios R, Elefteriou F, Glass DA, Lieberman MW, Karsenty G 2003 Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. Endocrinology 144: 27612764.
  • 350
    Wang L, Liu S, Quarles LD, Spurney RF 2004 Targeted overexpression of G protein-coupled receptor kinase 2 (GRK2) in osteoblasts promotes bone loss. Am J Physiol Endocrinol Metab 288: E826E834.
  • 351
    Justesen J, Mosekilde L, Holmes M, Stenderup K, Gasser J, Mullins JJ, Seckl JR, Kassem M 2004 Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation. Endocrinology 145: 19161925.
  • 352
    Kenner L, Hoebertz A, Beil T, Keon N, Karreth F, Eferl R, Scheuch H, Szremska A, Amling M, Schorpp-Kistner M, Angel P, Wagner EF 2004 Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J Cell Biol 164: 613623.
  • 353
    Bohlooly Y, Mahlapuu M, Andersen H, Astrand A, Hjorth S, Svensson L, Tornell J, Snaith MR, Morgan DG, Ohlsson C 2004 Osteoporosis in MCHR1-deficient mice. Biochem Biophys Res Commun 318: 964969.
  • 354
    van't Hof RJ, Macphee J, Libouban H, Helfrich MH, Ralston SH 2004 Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology 145: 50685074.
  • 355
    Sainsbury A, Baldock PA, Schwarzer C, Ueno N, Enriquez RF, Couzens M, Inui A, Herzog H, Gardiner EM 2003 Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol Cell Biol 23: 52255233.
  • 356
    Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA 2003 Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278: 19982007.
  • 357
    Kitahara K, Ishijima M, Rittling SR, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M 2003 Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 144: 21322140.
  • 358
    Hashimoto-Gotoh T, Ohnishi H, Tsujimura A, Tsunezuka H, Imai K, Masuda H, Nakamura T 2004 Bone mass increase specific to the female in a line of transgenic mice overexpressing human osteoblast stimulating factor-1. J Bone Miner Metab 22: 278282.
  • 359
    Daci E, Everts V, Torrekens S, Van HE, Tigchelaar-Gutterr W, Bouillon R, Carmeliet G 2003 Increased bone formation in mice lacking plasminogen activators. J Bone Miner Res 18: 11671176.
  • 360
    VanHouten JN, Dann P, Stewart AF, Watson CJ, Pollak M, Karaplis AC, Wysolmerski JJ 2003 Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 112: 14291436.
  • 361
    Chiusaroli R, Knobler H, Luxenburg C, Sanjay A, Granot-Attas S, Tiran Z, Miyazaki T, Harmelin A, Baron R, Elson A 2004 Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo. Mol Biol Cell 15: 234244.
  • 362
    Tsuchiya H, Kitoh H, Sugiura F, Ishiguro N 2003 Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 301: 338343.
  • 363
    Kim S, Koga T, Isobe M, Kern BE, Yokochi T, Chin YE, Karsenty G, Taniguchi T, Takayanagi H 2003 Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17: 19791991.
  • 364
    Geoffroy V, Marty-Morieux C, Le GN, Clement-Lacroix P, Terraz C, Frain M, Roux S, Rossert J, de Vernejoul MC 2004 In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res 19: 811822.
    Direct Link:
  • 365
    Devoto M, Specchia C, Li HH, Caminis J, Tenenhouse A, Rodriguez H, Spotila LD 2001 Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. Hum Mol Genet 10: 24472452.
  • 366
    Karasik D, Myers RH, Hannan MT, Gagnon D, McLean RR, Cupples LA, Kiel DP 2002 Mapping of quantitative ultrasound of the calcaneus bone to chromosome 1 by genome-wide linkage analysis. Osteoporos Int 13: 796802.
  • 367
    Niu T, Chen C, Cordell H, Yang J, Wang B, Wang Z, Fang Z, Schork NJ, Rosen CJ, Xu X 1999 A genome-wide scan for loci linked to forearm bone mineral density. Hum Genet 104: 226233.
  • 368
    Duncan EL, Brown MA, Sinsheimer J, Bell J, Carr AJ, Wordsworth BP, Wass JA 1999 Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res 14: 19931999.
  • 369
    Ota N, Hunt SC, Nakajima T, Suzuki T, Hosoi T, Orimo H, Shirai Y, Emi M 2000 Linkage of human tumor necrosis factor-alpha to human osteoporosis by sib pair analysis. Genes Immun 1: 260264.
  • 370
    Mitchell BD, Cole SA, Bauer RL, Iturria SJ, Rodriguez EA, Blangero J, MacCluer JW, Hixson JE 2000 Genes influencing variation in serum osteocalcin concentrations are linked to markers on chromosomes 16q and 20q. J Clin Endocrinol Metab 85: 13621366.
  • 371
    Harris SE, Guo D, Harris MA, Krishnaswamy A, Lichtler A 2003 Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: Role of Dlx2 and Dlx5 transcription factors. Front Biosci 8: s1249s1265.
  • 372
    Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, Bauer C, Meda P, Citi S 2004 Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci 117: 52455256.
  • 373
    von Schroeder HP, Veillette CJ, Payandeh J, Qureshi A, Heersche JN 2003 Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures. Bone 33: 673684.
  • 374
    Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, Weber RM, Ewerbeck V, Richter W 2003 Cartilage-like gene expression in differentiated human stem cell spheroids: A comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum 48: 418429.
  • 375
    Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, Brockbank SM, Edwards DR, Parker AE, Clark IM 2004 Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50: 131141.
  • 376
    Tardif G, Hum D, Pelletier JP, Boileau C, Ranger P, Martel-Pelletier J 2004 Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 50: 25212530.
  • 377
    Shi J, Schmitt-Talbot E, DiMattia DA, Dullea RG 2004 The differential effects of IL-1 and TNF-alpha on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells. Inflamm Res 53: 377389.
  • 378
    Elliott SF, Coon CI, Hays E, Stadheim TA, Vincenti MP 2002 Bcl-3 is an interleukin-1-responsive gene in chondrocytes and synovial fibroblasts that activates transcription of the matrix metalloproteinase 1 gene. Arthritis Rheum 46: 32303239.
  • 379
    Luo Q, Kang Q, Si W, Jiang W, Park JK, Peng Y, Li X, Luu HH, Luo J, Montag AG, Haydon RC, He TC 2004 Connective tissue growth factor (CTGF) is regulated by Wnt and BMP signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 5595855968.
  • 380
    van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL 2003 Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 48: 21322145.
  • 381
    Ohara N, Hayashi Y, Yamada S, Kim SK, Matsunaga T, Yanagiguchi K, Ikeda T 2004 Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide. Biomaterials 25: 17491754.
  • 382
    Zhang H, Liew CC, Marshall KW 2002 Microarray analysis reveals the involvement of beta-2 microglobulin (B2M) in human osteoarthritis. Osteoarthritis Cartilage 10: 950960.
  • 383
    Islam S, Kermode T, Sultana D, Moskowitz RW, Mukhtar H, Malemud CJ, Goldberg VM, Haqqi TM 2001 Expression profile of protein tyrosine kinase genes in human osteoarthritis chondrocytes. Osteoarthritis Cartilage 9: 684693.
  • 384
    Huh SJ, Paik DJ, Chung HS, Youn J 2003 Regulation of GRB2 and FLICE2 expression by TNF-alpha in rheumatoid synovium. Immunol Lett 90: 9396.
  • 385
    Gallagher J, Howlin J, McCarthy C, Murphy EP, Bresnihan B, FitzGerald O, Godson C, Brady HR, Martin F 2003 Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays. FEBS Lett 551: 812.
  • 386
    Takeoka Y, Kenny TP, Yago H, Naiki M, Gershwin ME, Robbins DL 2002 Developmental considerations of sperm protein 17 gene expression in rheumatoid arthritis synoviocytes. Dev Immunol 9: 97102.
  • 387
    Sakurai D, Yamaguchi A, Tsuchiya N, Yamamoto K, Tokunaga K 2001 Expression of ID family genes in the synovia from patients with rheumatoid arthritis. Biochem Biophys Res Commun 284: 436442.
  • 388
    de Jong DS, Vaes BL, Dechering KJ, Feijen A, Hendriks JM, Wehrens R, Mummery CL, van Zoelen EJ, Olijve W, Steegenga WT 2004 Identification of novel regulators associated with early-phase osteoblast differentiation. J Bone Miner Res 19: 947958.
  • 389
    de Jong DS, Steegenga WT, Hendriks JM, van Zoelen EJ, Olijve W, Dechering KJ 2004 Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells. Biochem Biophys Res Commun 320: 100107.
  • 390
    Gu K, Zhang L, Jin T, Rutherford RB 2004 Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Cells Tissues Organs 176: 2840.
  • 391
    Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, Luu HH, Park JY, Haydon RC, He TC 2003 Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 90: 11491165.
  • 392
    Korchynskyi O, Dechering KJ, Sijbers AM, Olijve W, ten Dijke P 2003 Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. J Bone Miner Res 18: 11771185.
  • 393
    Balint E, Lapointe D, Drissi H, van der MC, Young DW, van Wijnen AJ, Stein JL, Stein GS, Lian JB 2003 Phenotype discovery by gene expression profiling: Mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J Cell Biochem 89: 401426.
  • 394
    de Jong DS, van Zoelen EJ, Bauerschmidt S, Olijve W, Steegenga WT 2002 Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation. J Bone Miner Res 17: 21192129.
  • 395
    Vaes BL, Dechering KJ, Feijen A, Hendriks JM, Lefevre C, Mummery CL, Olijve W, van Zoelen EJ, Steegenga WT 2002 Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development. J Bone Miner Res 17: 21062118.
  • 396
    von Stechow D, Zurakowski D, Pettit AR, Muller R, Gronowicz G, Chorev M, Otu H, Libermann T, Alexander JM 2004 Differential transcriptional effects of PTH and estrogen during anabolic bone formation. J Cell Biochem 93: 476490.
  • 397
    Bourne S, Polak JM, Hughes SP, Buttery LD 2004 Osteogenic differentiation of mouse embryonic stem cells: Differential gene expression analysis by cDNA microarray and purification of osteoblasts by cadherin-11 magnetically activated cell sorting. Tissue Eng 10: 796806.
  • 398
    Lindberg MK, Moverare S, Eriksson AL, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, Ohlsson C 2002 Identification of estrogen-regulated genes of potential importance for the regulation of trabecular bone mineral density. J Bone Miner Res 17: 21832195.
  • 399
    Leclerc N, Luppen CA, Ho VV, Nagpal S, Hacia JG, Smith E, Frenkel B 2004 Gene expression profiling of glucocorticoid-inhibited osteoblasts. J Mol Endocrinol 33: 175193.
  • 400
    Eelen G, Verlinden L, van Camp M, van Hummelen P, Marchal K, de Moor B, Mathieu C, Carmeliet G, Bouillon R, Verstuyf A 2004 The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. J Bone Miner Res 19: 133146.
    Direct Link:
  • 401
    Beck GR Jr, Moran E, Knecht N 2003 Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res 288: 288300.
  • 402
    Raouf A, Ganss B, McMahon C, Vary C, Roughley PJ, Seth A 2002 Lumican is a major proteoglycan component of the bone matrix. Matrix Biol 21: 361367.
  • 403
    Huang W, Carlsen B, Rudkin GH, Shah N, Chung C, Ishida K, Yamaguchi DT, Miller TA 2001 Effect of serial passage on gene expression in MC3T3-E1 preosteoblastic cells: A microarray study. Biochem Biophys Res Commun 281: 11201126.
  • 404
    Carinci F, Piattelli A, Stabellini G, Palmieri A, Scapoli L, Laino G, Caputi S, Pezzetti F 2004 Calcium sulfate: Analysis of MG63 osteoblast-like cell response by means of a microarray technology. J Biomed Mater Res 71B: 260267.
  • 405
    Carinci F, Pezzetti F, Volinia S, Laino G, Arcelli D, Caramelli E, Degidi M, Piattelli A 2004 P-15 cell-binding domain derived from collagen: Analysis of MG63 osteoblastic-cell response by means of a microarray technology. J Periodontol 75: 6683.
  • 406
    Izzo MW, Pucci B, Tuan RS, Hall DJ 2002 Gene expression profiling following BMP-2 induction of mesenchymal chondrogenesis in vitro. Osteoarthritis Cartilage 10: 2333.
  • 407
    Clancy BM, Johnson JD, Lambert AJ, Rezvankhah S, Wong A, Resmini C, Feldman JL, Leppanen S, Pittman DD 2003 A gene expression profile for endochondral bone formation: Oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps. Bone 33: 4663.
  • 408
    Li V, Raouf A, Kitching R, Seth A 2004 Ets2 transcription factor inhibits mineralization and affects target gene expression during osteoblast maturation. In Vivo 18: 517524.
  • 409
    Lotinun S, Sibonga JD, Turner RT 2002 Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression. Endocrine 17: 2936.
  • 410
    Nakazawa T, Nakajima A, Seki N, Okawa A, Kato M, Moriya H, Amizuka N, Einhorn TA, Yamazaki M 2004 Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis. J Orthop Res 22: 520525.
  • 411
    Nagel DE, Khosla S, Sanyal A, Rosen DM, Kumagai Y, Riggs BL 2004 A fragment of the hypophosphatemic factor, MEPE, requires inducible cyclooxygenase-2 to exert potent anabolic effects on normal human marrow osteoblast precursors. J Cell Biochem 93: 11071114.
  • 412
    Stock M, Schafer H, Fliegauf M, Otto F 2004 Identification of novel genes of the bone-specific transcription factor Runx2. J Bone Miner Res 19: 959972.
  • 413
    Hatano H, Siegel HJ, Yamagiwa H, Bronk JT, Turner RT, Bolander ME, Sarkar G 2004 Identification of estrogen-regulated genes during fracture healing, using DNA microarray. J Bone Miner Metab 22: 224235.
  • 414
    Segev O, Samach A, Faerman A, Kalinski H, Beiman M, Gelfand A, Turam H, Boguslavsky S, Moshayov A, Gottlieb H, Kazanov E, Nevo Z, Robinson D, Skaliter R, Einat P, Binderman I, Feinstein E 2004 CMF608-a novel mechanical strain-induced bone-specific protein expressed in early osteochondroprogenitor cells. Bone 34: 246260.
  • 415
    Meyer MH, Etienne W, Meyer RA Jr 2004 Altered mRNA expression of genes related to nerve cell activity in the fracture callus of older rats: A randomized, controlled, microarray study. BMC Musculoskelet Disord 5: 24.
  • 416
    Pacicca DM, Patel N, Lee C, Salisbury K, Lehmann W, Carvalho R, Gerstenfeld LC, Einhorn TA 2003 Expression of angiogenic factors during distraction osteogenesis. Bone 33: 889898.
  • 417
    Hadjiargyrou M, Lombardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White DW, Rubin CT 2002 Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem 277: 3017730182.
  • 418
    Joo J, Ahn H, Lombardo F, Hadjiargyrou M, Zhu W 2004 Statistical approaches in the analysis of gene expression data derived from bone regeneration specific cDNA microarrays. J Biopharm Stat 14: 607628.
  • 419
    Etienne W, Meyer MH, Peppers J, Meyer RA Jr 2004 Comparison of mRNA gene expression by RT-PCR and DNA microarray. Biotechniques 36: 618626.
  • 420
    Farach-Carson MC, Xu Y 2002 Microarray detection of gene expression changes induced by 1,25(OH)(2)D(3) and a Ca(2+) influx-activating analog in osteoblastic ROS 17/2.8 cells. Steroids 67: 467470.
  • 421
    Fujita M, Urano T, Horie K, Ikeda K, Tsukui T, Fukuoka H, Tsutsumi O, Ouchi Y, Inoue S 2002 Estrogen activates cyclin-dependent kinases 4 and 6 through induction of cyclin D in rat primary osteoblasts. Biochem Biophys Res Commun 299: 222228.
  • 422
    Harvey CB, Stevens DA, Williams AJ, Jackson DJ, O'Shea P, Williams GR 2003 Analysis of thyroid hormone responsive gene expression in osteoblastic cells. Mol Cell Endocrinol 213: 8797.
  • 423
    Qin L, Qiu P, Wang L, Li X, Swarthout JT, Soteropoulos P, Tolias P, Partridge NC 2003 Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem 278: 1972319731.